Enovis Quarterly Income Statement
NYSE: ENOVHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Enovis revenue and earnings
In the quarter ended Jul 3, 2026, Enovis generated $582.8 million in revenue, up 3.2% from the same quarter a year earlier. Enovis reported a net loss of $1.2 million, compared with a loss of $36.7 million a year earlier. Gross margin was 61.6% (up from 59.3%) and operating margin 3.0%.
Diluted earnings per share came in at -$0.02.
Summary generated from market data by MetaCap's automated system. Methodology
Enovis income statement (quarterly)
| Quarter (USD) | Q2 20262026-07-03 | Q1 20262026-04-03 | Q4 20252025-12-31 | Q3 20252025-10-03 | Q2 20252025-07-04 | Q1 20252025-04-04 | Q4 20242024-12-31 | Q3 20242024-09-27 | Q2 20242024-06-28 | Q1 20242024-03-29 | Q4 20232023-12-31 | Q3 20232023-09-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 582.78M | 589.15M | 575.76M | 548.91M | 564.54M | 558.83M | 560.98M | 505.22M | 525.16M | 516.27M | 455.02M | 417.52M |
| Revenue growth (YoY) | +3.23% | +5.43% | +2.64% | +8.65% | +7.50% | +8.25% | +23.29% | +21.00% | +22.56% | +27.11% | +11.33% | +8.78% |
| Cost of Revenue | 223.53M | 223.67M | 226.34M | 220.00M | 229.85M | 226.60M | 253.46M | 218.76M | 236.28M | 218.37M | 190.63M | 174.56M |
| Gross Profit | 359.25M | 365.49M | 349.42M | 328.91M | 334.70M | 332.23M | 307.52M | 286.46M | 288.88M | 297.90M | 264.39M | 242.97M |
| Operating Expenses | 341.84M | 358.95M | 851.60M | 887.40M | 351.49M | 379.00M | 972.27M | 318.20M | 333.10M | 332.91M | 270.14M | 263.46M |
| Research & Development | 31.69M | 31.53M | 31.36M | 29.74M | 30.70M | 28.53M | 23.95M | 20.49M | 23.48M | 23.38M | 18.32M | 19.90M |
| Selling, General & Admin | 263.73M | 282.81M | 270.44M | 263.62M | 267.07M | 269.02M | 257.71M | 249.85M | 264.10M | 255.69M | 211.01M | 204.25M |
| Operating Income | 17.41M | 6.53M | -502.18M | -558.49M | -16.80M | -46.77M | -664.75M | -31.74M | -44.22M | -35.01M | -5.75M | -20.49M |
| Interest Expense | 8.04M | 9.17M | 7.51M | 8.83M | 9.29M | 9.19M | 9.07M | 11.07M | 16.97M | 20.00M | 4.25M | 5.77M |
| Other Income (Expense) | -1.91M | 3.27M | 141.00K | 448.00K | 436.00K | -1.39M | 92.00K | 202.00K | 33.84M | -24.23M | 25.00M | 757.00K |
| Pretax Income | 7.46M | 634.00K | -509.55M | -566.87M | -25.65M | -57.35M | -673.73M | -42.60M | -27.35M | -79.25M | 7.66M | -25.50M |
| Income Tax | 8.50M | 9.04M | 9.26M | 4.00M | 10.80M | -1.77M | 29.90M | -9.10M | -8.91M | -7.40M | 4.59M | -6.05M |
| Net Income | -1.19M | -8.76M | -520.59M | -571.15M | -36.74M | -55.97M | -703.34M | -31.52M | -18.64M | -72.00M | 2.96M | -2.88M |
| Net Income growth (YoY) | — | — | — | — | — | — | -23829.32% | — | — | — | — | — |
| EPS (Basic) | -0.02 | -0.15 | -9.14 | -9.99 | -0.64 | -0.98 | -12.69 | -0.58 | -0.34 | -1.32 | 0.05 | -0.05 |
| EPS (Diluted) | -0.02 | -0.15 | -9.14 | -9.99 | -0.64 | -0.98 | -12.69 | -0.58 | -0.34 | -1.32 | 0.05 | -0.05 |
| Shares Outstanding (Basic) | 57.60M | 57.31M | — | 57.17M | 57.13M | 56.79M | — | 55.67M | 54.86M | 54.69M | — | 54.55M |
| Shares Outstanding (Diluted) | 57.60M | 57.31M | — | 57.17M | 57.13M | 56.79M | — | 55.67M | 54.86M | 54.69M | — | 54.55M |
| EBITDA | 88.44M | 79.89M | 624.58M | -484.11M | 54.76M | 24.67M | 52.69M | 39.49M | 21.54M | 38.39M | 50.86M | 34.97M |
| Gross Margin | 61.64% | 62.04% | 60.69% | 59.92% | 59.29% | 59.45% | 54.82% | 56.70% | 55.01% | 57.70% | 58.10% | 58.19% |
| Operating Margin | 2.99% | 111.00% | -87.22% | -101.74% | -2.98% | -8.37% | -118.50% | -6.28% | -8.42% | -6.78% | -126.00% | -4.91% |
| Net Margin | -20.00% | -149.00% | -90.42% | -104.05% | -6.51% | -10.01% | -125.38% | -6.24% | -3.55% | -13.95% | 65.00% | -69.00% |
This table shows 12 quarterly periods of Enovis's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow ENOV's reporting calendar. What is a income statement?